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ABSTRACT
A series of in vivo experiments was undertaken for the purpose of
determining what effects prostaglandin F2o( compound would have on a
number of endocrine organs and reproductive structures of immature female
rats.

The pituitary, thyroid, uterus, vaginal canalization, ovarian

progesterone biosynthesis and body weights were carefully analyzed.
The procedures included the chronic administration of PGF2o<. (0.075 mg,
BID) in 30 twenty-two day old female albino rats.

.

On days 27, 33 and

37, ten rats were necropsied and their body and organ weights were
recorded.

Vaginal canalization was noted at this time.

All tissues

were formalin-fixed while the ovaries were quick frozen in liquid nitrogen for progesterone biosynthesis determination, by way of semi-quantitatively assessing the histochemical detection and intensities of pregnenolone-3B-hydroxysteroid dehydrogenase.
Other experimental groups that paralleled the prostaglandin group
included a prostaglandin antagonist (aspirin), and two adenohypophyseal
gonadotropins, Follicle Stimulating Hormone (FSH) and Luteinizing Hormone
(UI).

The controls included a non-injected group and an alcohol (aspirin

vehicle) injected group.
The results indicated that the basic biological responses of immature
rats to PGF 2o( administration included increased ovarian progesterone
biosynthesis as determined by enzyme histochemical techniques, and premature sexual development as witnessed by early vaginal canalization.

BOth of these responses were significant and were related to the exogenous
prostaglandin compound.

No significant differences could be detected

either gravimetrically or histologically among the thyroid glands, pituitary glands and uteri of the prostaglandin group versus the control
groups.
The aspirin group revealed stunted growths and delayed sexual development, but aspirin toxicity, however slight, could not be ruled out.
The selected gonadotropins, FSH and UI, yielded variable responses
which raised doubts about their purity.

FSH, however, did show a pro-

gressively decreasing amount of ovarian progesterone biosynthesis activity,
while the LH injected group could not be distinguished from the normal
control group.
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INTRODUCTION
prostaglandins are hormone-like substances that are widely distributed in human and animal tissues.

They are believed to be intracellular,

metabolic regulators that stimulate or inhibit the action of many hormones.
Their remarkably wide range of pharmacologic effects has excited worldwide scientific interest.

On the horizon now are potential medical uses

of prostaglandins for numerous and diverse clinical problems,

~·a·

labor

induction, therapeutic abortion, contraception and hypertension control.
Prostaglandins are 20-carbon acidic lipids whose metabolic precursors
are the essential fatty acids.

There are fourteen known prostaglandins;

they are widely distributed in small amounts throughout the animal kingdom.

Although very rapidly metabolized, prostaglandins are one of the

most potent chemicals ever discovered, one millionth of a gram producing
marked effects.
A rather confusing combination of Greek and Roman letters is used
to identify these compounds,

i

~·

A, E1 , F 2 ~.

Of the fourteen prosta-

glandins, thirteen occur in man, ~ith the highest concentration in
human seminal fluid.

Their wide range of physiologic effects can be

shown by prostaglandin E2 ,

the most thoroughly studied, which not only

stimulates smooth muscle, lowers blood pressure, inhibits gastric secretions and inhibits platelet aggregation, but also inhibits lipolysis
and acts as a nasal vasoconstrictor, bronchodilator, causes sedation,
produces optical miosis, and increases intraocular pressure.

In general,

the E and A groups of prostaglandins have vasodepressor effects while the

---
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p gro Up tends to raise blood pressure.

Both groups will induce labor and

are used for therapeutic abortions.
There has been much interest in prostaglandin research in recent years
mainly due to larger supplies of a purer substance.

The greater interests

into the effects of prostaglandins at the present time seem to be focused
on the female reproductive systems of mature mammals.

Little interest,

however, has been given to the effects of prostaglandins on immature
mammals.

Therefore, it seemed pertinent to initiate some studies and

experimental trials which could provide more detailed information concerning the nature of the effects of prostaglandins during the period of
transition from immaturity to maturity.
For determining a possible action site of prostaglandins, a prostaglandin antagonist, acetylsalicylic acid (aspirin), was used in one
experimental trial group.

Two gonadotropins, Follicle Stimulating Hor-

mone (FSH) and Luteinizing Hormone (LR), were used in additional experimental groups to differentiate any similarity between their responses
and the prostaglandin responses.
The organs selected for study were the pituitary, thyroid and uterus.
Vaginal canalization was used as the index of puberty and frozen ovaries
were processed to study possible progesterone biosynthesis activity.
There are no classical monographs on this subject to refer to, and
this thesis is intended to add new lines of information so that we can
better understand the nature of PGF2o'. •

This study is the first such

attempt to record the chronic effects of prostaglandins on the selected

--
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organ systems of developing immature rats by thorough assessments of the
sequelae of the changes over short time intervals.

Such a study can make

a significant contribution to the knowledge of prostaglandin research
because it measures the total animal response
administered prostaglandins.

of the animal to chronically

ii.

-
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REVIEW OF THE LITERATURE
The proliferation of prostaglandin research is a fairly recent development.

Three Swedish investigators did the pioneer work:

Professor

U.S. von Euler, coiner of the term "prostaglandin"; Sune Bergstrom and
isengt samuelsson.

Isolation and determination of the structure of PGE 1

and PGF , eleven years ago by Bergstrom (1962), gave a great impetus
1
to research work.
During the first decade after prostaglandins were discovered in
1930 by Kurzrok and Lieb, all research was conducted in a single laboratory,!.-~·

that of Professor von Euler.

After World war II, Bergstrom

took on the job of attempting to isolate, identify and purify the substances.

In 1957, the Bergstrom team isolated PGE 1 and PGF1 in pure

crustalline form and during the next five years developed the advanced
chromatographic techniques to precisely define the chemical structure of
their compounds.
The impetus for further biological work resulted from the elegant
isolation and chemical identification achieved by Bergstrom, Sjovall,
Samuelsson and their co-wrokers.

Bergstrom and Sjovall (1957)

isolated

two compounds which behaved differently on partition between ether and
an aqueous phosphate buffer.

The one more soluble in ether was called

prostaglandin E (PGE), the other, more soluble in phosphate buffer was
called prostaglandin F (PGF).
formulae

c20H34 o5

and

c20H36 o5

These compounds were assigned the empirical
respectively.

Total chemical synthesis

5

of all the major natural prostaglandins is now possible as a result of
the elegant methods devised by E. Corey,

~

!.!_. (1969).

These have

already proven feasible for commercial production.
It is clear that within the next decade thousands of prostaglandin
analogues will be synthesized.

One can, therefore, anticipate that

compounds with more specific and more potent biological activities, as
well as antagonists to prostaglandins, will become available for both
clinical and research use.

Prostaglandin antagonists, like aspirin and

indomethacin, are anti-inflammatory drugs which can block prostaglandin
synthesis (Smith and Willis, 1971; vane, 1971).
The basic question in prostaglandin research is to define the
normal function of this wide array of substances.

This remains, for the

most part, not answered, but many theories exist; facilitating ejaculation
(von Euler, 196 7), a menstrual "stimulant" (Pickles, 1959), a role in
parturition

(Karim,~

endocrine function

al., 1969), and an anti-hypertensive renal

(Lee~!.!_.,

1971).

Major contributions to knowledge of the metabolic pathways of the
prostaglandins came from Hamberg and Samuelsson who, in 1966, isolated
and identified the eight naturally occurring metabolites of the six
primary prostaglandins.

Steinberg and his co-workers (1963) made the

original observation that PGEl inhibits hormone-induced lipolysis.
conclusions that were made included the possibilities that PGE

1

The

inhibits

6

the enzyme adenyl cyclase, and that this inhibition is an indirect action
c111mwell and shaw, 1970).
on the other hand, there is abundant evidence that pn many tissues,
p~

compounds, although affecting adenyl cyclase, do not inhibit the

related hortn)ne but instead mimics that hormone's action.
like corticotropin, stimulates corticosteroidogenesis
IC11neko

~al.,

(1969) has shown PGE

stimulating hormone (TSH).

1

Thus PGE 2 ,

(Flack~

al., 1969).

to mimic the action of thyroid

PGE1 also stimulates insulin secretion with

cyclic AMP acting as the mediator.

It may be concluded that interactions

between PGE compounds and adenyl cyclase may underlie many of the effects
produced by prostaglandins but no hypothesis has yet explained the mode
of action of the PGF or PGA compounds.
It has been hypothesized that prostaglandins are probably synthesized in all or in most cells and in all species and that the primary
mechanism of action of prostaglandins is on the plasma membrane and its
association with adenyl cyclase and adenosine 3', 5'-monophosphate (Cyclic
AMP) (Butcher,

~

al., 196 7).

Cyclic AMP,, described as a "second messen-

ger system" - the hormone being the first messenger - is believed to
mediate most, if not all, hormone actions.

Cellular regulation of the

response of a tissue to hortn)nal stimulation by prostaglandins has also
been indicated, since exogenous prostaglandins can modify the hormonal
responses of the tissue (Shio, ~ !!.!,., 1971).

-
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prostaglandins can increase cyclic AMP levels in many tissues in
what appears to be a nonspecific manner.

No

qualitative differences

have been observed between the groups of prostaglandins in their ability
to

increase the intracellular accumulation of cyclic AMP, but Butcher,

et a 1 • , ( 1967), has found the PGE group to be generally more potent than

--

the PGF series.
studies by Ramwell and Shaw (1970) regarding the effect of tissue·

stimulation on endogenous prostaglandins have indicated that more prosta$1andins are released than can be extracted, suggesting the activation
of a biosynthetic process rather than the release from a preformed store.
It has, therefore, been hypothesized that prostaglandins interact with
cyclic AMP, thereby mimicking certain hormones - oxytocin, ACTH, follicle
stimulating hormone.
It is becoming clearer that prostaglandins are involved in the response of a tissue to hormonal stimulation but the determination of the
exact role awaits elucidation of whether the biosynthesis and release of
prostaglandins results from a direct effect of the hormones or whether
it is secondary to changes in cyclic AMP levels.
I.

Circulation of Prostaglandins
Prostaglandins are released into the circulation from different

organs, but a very high proportion of PGE and PGF compounds are metabolized
on one circulation through the lungs.

!~;
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Fifteen minutes after the intravenous injection of

PGF2~

in mice,

net al., (1967),showed most of the compound was concentrated in the

aree - -

liver, kidneys and subcutaneous connective tissue.

No significant

amounts could be demonstrated in the other organs including the endocrine
glands.

PGF2« does reach the uterine venous blood, however, under

physiological conditions, and has been identified as simulating the
action of luteolysin
Bland,~!!_.,

1971).

(Poyser,~

2

PGF ~,

al., 1970;

Blatchley~

al., 1971;

although stable in blood, is 95% removed

from the circulation on one passage through the lungs; furthermore, 80%
of the prostaglandins are removed by the liver via the portal system
(Ferreira and vane, 1967).
II.

Prostaglandi

i

Actions on the Thyroid.

very little has been done regarding the effects of prostaglandins
on the thyroid gland.

In canine thyroid slices, PGE 1 mimics the actions

of thyroid stimulating hormone (TSH), (Onaya and Solomon, 1970; Zor et

!.!·•

1960).

It is suggested, therefore, that PGE 1 is functional in the

secretion of thyroid hormone which is initiated by TSH
1969).

(G~imley, ~al.,

It should.be mentioned that these were in vitro studies and only

speculations can be made on the in vivo environment.

---

III.

Prostaglandin Actions on the Uterus.
Extensive studies of prostaglandins and the uterus have progressed

to therapeutic applications of the prostaglandins and clinical trials.

9

JCl&rim (1971) has performed clinical trials in Uganda and has reported that
A

p(J! 2 and PGF 2""

administered orally will induce labor in the later stages

of pregnancy in humans without serious side effects.

Investigations

concerning prostaglandins and the uterus have attempted to determine
their role in the pregnant and non-pregnant uterus.
The non-pregnant uterus is stimulated by

PGF 1 ~

and

PGF 2 ~

compounds

which are found in menstrual fluids; while the PGE compounds, found in
high concentrations in seminal fluids, inhibit myometrial activity
(Bygdeman and Hamberg, 1967).

This general statement must be modified in

view of investigations which show that the stage of the ovarian cycle
is important.

Human myometrium is more sensitive to inhibition by PGE

at midcycle near ovulation (Eliasson, 1963) and more sensitive to

PGF ~

stimulation just before menstruation

(Pickles,~

pregnancy (von Dorp,

This is probably related to the

~al.,

1964).

changing levels of the ovarian steroids.

2

al., 1965) and during

It is suggested, therefore,

that the physiologic role of PGE in semen is to facilitate sperm migration and subsequent capacitation and fertilization.
The pregnant uterus, in contrast to the non-pregnant uterus, responds
differently to the prostaglandin compounds.

Both PGE

2

and PGF 2 ~ are

apasmogenic on upper uterine muscle strips, but inactive on lower muscle
segments (Embrey and Morrison, 1968).

Additional follow-up studies by

R'ilrim (1968) showed that PGF2 ~ was consistently found in venous blood
of patients in labor, but absent in women who needed surgical deliveries
or those women not in labor.

The source of this PGF 2~ , according to

10

IOlrim and Devlin (1967), is the placenta.
As the investigation and research continues into the effects of
prostaglandins on the uterus, interesting speculations have arisen, all
of which are still under serious consideration.
l{irton
8

~al.,

(1970) has proven the successful role of

contraceptive when given after ovulation in primates.

this effect to be caused by the luteolytic properties of

PGF ~

2

as

They have shown
PGF 2 ~

and have

hypothesized this to be the specific factor which normally causes the

.

corpus luteum to regress each month if no pregnancy occurs.

This has

opened a new approach to female contraception whereby prostaglandins may
be administered once each month as compared to the conventional birth
control pills (Karim and Sharma, 1971).
Bygdeman and Samuelsson (1966) have investigated PGE 1 s role into
human male infertility and have suggested that 8% of male infertility
might be due to PGE deficiency.

PGE 1 s role in preventing gastric and

duodenal ulcers in rats and dogs has been strongly suggested by Shaw
and Ramwell (1968).

When administered as aerosols, PGE 1 will act as a

bronchodilator according to Jackson (1970) with this decongestant, such
effect lasting up to 14 hours.
The PGA group has been selectively researched into the area of hypotensive effects because they are not quickly metabolized and inactivated
in contrast to the PGE and PGF groups. Lee~!!,., (1971) has shown the
marked reduction in blood pressure in hypertensive patients by the infusion

Of PGA..

11

A final comment to be made concerning the effects of prostaglandins
on the endocrine and reproductive systems is that many statements and
facts are being made, but that no acceptable proven hypothesis governing
prostaglandin action thus far has been established.
only resulted in speculations.

Investigations have

The intensity of research into this

area will undeniably shed new light on their true significance.
questions remain unanswered.

Many
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MATERIALS AND METHODS
1. Aun~i~ma::::.:l~s_.;..a_n_d_H_o~u_s_in_g~.
::;,...
A total of 190 immature (21 day old) Sprague-Dawley derived female

rats (tocke-Erickson Laboratories, Maywood, Illinois) were separated
randomly into 19 experimental groups.

Rats were housed five to a unit

in clear plastic "shoe-box" shaped cages (10.5 X 19 X 8.5 inches) on Sani·cell bedding (Paxton Laboratories, Paxton, Illinois).

Chow) and water were provided ad libitum.

Feed (Purina I.ab

They were all housed in the

same environmentally controlled room where the temperature (72±2° F),
humidity (43±5%) and a 12 hour light cycle remained constant.
11.

Experimental Groups.
1.

All injections were given subcutaneously using a tuberculin

syringe and a 26 gauge needle; they were given twice daily (8 a.m. and
4 p.m.).

Two major control groups were defined:

a non-injected normal

control group and an alcohol-injected control group injected with 0.25
cc of 10% ethanol.

This was necessary because alcohol was the vehicle

for the acetylsalicylic

acid~

Ten non-injected controls were necropsied

at 22 days to establish baseline values.

Then, successive groups of 10

rats from both control groups were necropsied at ages of 27, 33 and 37
days, i·~· after 5, 11 and 15 days of treatment.
2.

The prostaglandin group was injected with 0.075 mg of PGF20,

twice daily (0.075 cc,BID) from day 22 through the day prior to termination
on days 27, 33 and 37.

The PGF 2 ~ was delivered frozen at a concentration

13
of

rog/ml in. a phosphate buffer from G.D. Searle Co., Skokie, Illinois.
10
This was further diluted to a concentration of 0.1 mg/ml with a phosphate
S

J>uffer
• 6o"

c

olution and then dispensed into 1.00 cc aliquots and refrozen at

until used.

3.

The aspirin (acetylsalicylic acid) was dissolved with 10%

ethanol and injected at dosages of 5 mg (0.25 cc) BID.

The injections

were started on day 22 and continued up to the termination on days 27,
33 and 37.
4.

The LH (Schwarz-Mann, Orangeburg, New York) injected rats were

given 0.125 Armour Unit (LH-ovine, Armour, 277-80 equivalent to NIH-LR-Si)
BD> from day 22 until time of sacrifice on days 27, 33 and 37.

The LH

was received lyopholized and was reconstituted with sterile saline to

··"-·~··

.

deliver a dose of 0.05 cc.
5.

The FSH (Schwarz-Mann, Orangeburg, New York) injected rats were

given 0.25 Armour Unit (FSH-porcine, Armour, 264-15lx equivalent to 0.5
NIH·FSH-S ), BID in a 0.05 cc dose.
1

The injections began on day 22 and

continued up to termination on days 27, 33 and 37.
The age of the immature rat and this determination of the necropsy
dates were made to coincide with the specific growth periods of the reproductive system as described by Kasprow (1969).
III.

Procedures.
Rats were euthanized and necropsied after recording body weight to
nearest gram on a direct reading torsion balance and killing by ether

14

anes th

esia followed by decapitation.

time of necropsy.

Vaginal openings were recorded at

The pituitary, thyroid, ovaries and uterus were dis-

iected free and weighed to the nearest 0.2 mg on a Roller-Smith type torsion balance.

In cases where the uterus wad distended with fluid, incis-

ions were made to drain the fluid and the uterus was blotted dry with
bibulous paper.

After weighing, half of the thyroids, uteri and ovaries

were _fixed in buffered formalin and the other half were quick frozen in
liquid nitrogen and stored at -60° C.

The pituitaries were fixed in a

Jouin's-Holland solution.
The formalin-fixed tissues were then washed, dehydrated, cleared and
embedded

in paraffin blocks.

Sections were taken at six microns and

stained with the standard Harris hematoxylon and eosin stain.

Photo-

micrographs were taken using a Wild microscope and Polaroid 107 type
film at lOOX magnifications for comparison.
The ovaries that were frozen were sectioned at eight microns and
incubated for 3~ hours in a media containing pregnenolone, propylene glycol,
nictotinamide-adenine dinucleotide (NAD) and nitro blue tetrazolium chloride
(Nitro-BT), all in a phosphate buffer solution (pH 7.4) (Wattenberg, 1958).
A set of companion ovarian sections were incubated in media without pregnenolone and served as control groups.

Polaroid photomicrographs were

taken of the incubated sections to determine and neasure the semi-quantitative reactions.

15
This particular technique allows for the localization and semi-quan-

tita ti
•
0118

on of the enzyme pregnenolone-3p-hydroxysteroid dehydrogenase (P-

p-HSD), which is indicative of active progesterone biosynthesis.

3

'l'be intensity of activity was rated on a scale of 0 to +5, depending on
the degree of monoformazan and diformazan precipitate on the ovarian
tissue, (Plates I-III).

16
EXPERIMENTAL RESULTS

l·

9'ntro 1 Groups.
Gravimetric analyses of body, thyroid, pituitary and uterine weights

of the innnature female rats revealed a linear progression of increasing
weights.

The :OOdy, pituitary and uterine weights show a greater than 100%

increase in size from day 22 to day 33, for body weights, 41 mg to 92 mg;

a 100% increase for pituitary weights, 2.2 mg to 4.4 mg; and a greater than
300% increase for uterine weights, 20.2 mg to 85.2 mg (Table I).

The thy-

roid gland increased approximately 80% during this same time period, i.e.

4. 7 to 8.4 mg.
As would normally be expected the mg% values of the thyroid and
pituitary glands began to decline as the rats passed the 27th day; the
gland growth slowing while the body growth continued, 11.5 to 7.9 and
5.4 to 4.2 respectively.
past the 27th day,

i·~·

The uterine mg% values became rather constant
92.0 at 33 days and 92.5 at 37 days.

The standard

deviations of these uterine weights increased considerably as the animal
matured because of the beginning hormonal activity of their reproductive
systems, and such variations can be expected in this age range (Kasprow,

1969).
From the tabular data, one observes the fact that up to day 33,
100% of the animals were sexually immature, as manifested by closed vaginae
Thereafter, by day 37, 100% became sexually mature.

This five day range

of vaginal canalization is acceptable as a normal range when the animals
are of an inbred strain and housed together (Locke, 1971).

17
The pregnenolone-3p-HSD activity displayed by the ovaries of the conups was of minimal intensity at 27 days with a 75% increase in
tro 1 gro
activity intensities by day 33 (Table V, Text Figure V). This progesterone biosynthetic capability remained constant from day 33 to day 37.
It is interesting to recall that the uterine mg% weight also remained
constant from day 33 to day 37.
II.

prostaglandin Group.
The body weights of the chronically injected prostaglandin rats

were always lighter than the controls, but the differences were not significant, i·~· 55 gm~ 59 gm at 27 days; 90 ~ 92 at 33 days; 120 vs 123
at 37 days (Tables I-IV).

Gravimetric analysis of the thyroid glands from

days 22 to 27 showed no significant differences from the control,
6.7

mg!! 6.9 mg at day 27; 8.4

~

8.4 at day 33; 10.0

~

i·~·

9.6 at day 37.

The same was true for their mg% values (Text Figure I, and Tables I-IV).

The pituitary weights were almost identical with those of the control
groups as were the mg% values,
4.4 at day 33; 5.2

~

i·~·

3.0 mg vs 3.2 mg at day 27; 4.3

~

5.2 at day 37, (Text Figure II, and Tables I_:-IV).

The uterine weights of the prostaglandin injected rats were comparable at day 27 and became progressively lighter than the controls,

!·~·

34.2 mg~ 34.0 at day 27; 75.9 vs 85.2 at day 33; 107.9 ~--114.2 at day
37, (Text Figure III and Tables I-IV).

No statistical significance could

be_detected. Needless to say, the large standard deviation values due to
the sexual maturation and uterine responses may have hidden or masked any
real growth differences which may have, in fact, existed.

Analyzing

uterine weights during first ovulations may prove an interesting field of
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endeavor.
sbo'W any

The. histological observations on all these tissues failed to
detectable differences from the normal morphology of the controls.

The most significant finding of the PGF~-injected immature female
rats was the premature sexual maturation which was evidenced by 90% of

the rats by day 33, (Text Figure IV).

In rats, the vaginal opening

occurs near the time of the first ovulation and is used as an index of
puberty.

on day 33, none of the control vaginae were open and this dif-

ference was significant using the student's t-test (P=<0.001), (Table III).
BY day 37, all the rats in the prostaglandin and control groups were open.
The tabulated data of the semi-quantitative histochemical estimates
of f-one-3p-HSD activity of the PGFio. rat ovaries displays a significantly
greater intensity of activity on days 27 and 37, than on day 33 when it
fails to show a similar difference, i.e. 4.0

!!. 3.0 at day 33; 4.2

~

!!. 1.8 at day 27; 2.3

3.0 at day 37, (Text Figure V, Figure V).

'lbis early progesterone biosynthesis is interesting because it may provide a clue as to how subcutaneously administered PGF 2()(. can exert its
effects on the biological response of premature sexual maturity as witnessed by the early vaginal canalizations.'

nI.

Aspirin Group.
Gravimetric analyses of the body weights revealed a consistantly

lighter weight which was becoming progressively lighter than the controls,

!·!·

-

-

54 gm vs 59 at day 27; 89 vs 92 at day 33; 110 vs 123 at day 37,

-

(Tables I-IV).

The general appearance of these rats towards day 37 ·
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ted the possibility of an aspirin toxicosis because of the roughened
augges
.
drJ h8ir coat, mild emaciation and dehydration. But despite this general
appearanc e

and smaller weight size, the endocrine gland weights were com-

the normal controls if not larger.
parab 1e to
The thyroid gland was variable in its weight comparisons, but none
were significantly different from the control thyroids,
6

!.·~·

.9 at day 27; 8.9 vs 8.4 at day 33; 9.2 Y!. 9.6 at day 37.

6.0 mg Y!.
The uterine

weights of the aspirin injected rats were all lighter than the controls
but again no statistical significance could be detected because of the
large values of the standard deviations, !.·~· 26.6 mg Y!. 34.0 mg at day
27; 70.9 Y!. 85.2 at day 33; 109.3 Y!. 114.2 at day 37, (Tables I-IV, Text
Figure I).
The pituitary gland, on the other hand, was somewha,t larger than those
of the controls on day 27 (3.4 mg Y!. 3.2 mg) and this small difference
was significant (P=<0.05) (Table II).

This was an interesting finding

because aspirin, a prostaglandin antagonist, blocks the biosynthesis of
endogenous prostaglandins, and any blockage of prostaglandins would have
decreased the weight of an end organ, unless a negative feedback mechanism
,.as operating.

This larger value could also be regarded as part of an

aspirin toxicity phenomena which would render it meaningless for our
purpcses.

The successive values of the pituitary weights on days 33 and

37_were 4.5 mg and 5.8 mg compared to the control values of 4.4 mg and
S,2 mg respectively; neither values were significantly different than
those of the controls, (Tables I-IV, Text Figure II).
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A delayed sexual maturity was observed in the aspirin-treated rats
88

witnessed by the failure of vaginal

153

cana~ization

by day 37.

Only

of the rats displayed open vaginae by day 37 compared to 100% of the

control rats, {Text Figure IV).

This lag in sexual maturity may have been

caused by either of two initiating factors.

Either the possible aspirin

toxicity was effective enough in its manifestations to stunt or retard
normal growth because of its toxicity, or the aspirin used did, in fact,
block the prostaglandins which are involved with the production of and
biological responses to the ovarian steroids.
further experimental trials must be done;

To establish this fact,

one can' only speculate with

the results obtained so far.
The semi-quantitative analyses of the

pregnenolone-3~-HSD

intensity

in the ovaries of the aspirin injected rats revealed a variable linear
relationship between the aspirin and the control groups.
was greater than the control (2.3

~

The 27 day value

1.8); the 33 day values were equal

at 3.0; while the 37 day value was less than that of the control, i.e.
2.5 !!_ 3.0 respectively.

None of these aspirin-elicited values were of

statistical significance, (Table

v,

Text Figure V).

IV. The Follicle Stimulating Hormone {FSH) and Luteinizing Honnone (LR)
Groups.
Gravimetric analyses of the FSH and LR groups yielded significant
differences in the pituitary, thyroid and uterus, body weight and vaginal
canalization, but the purity of these compounds must be questioned because
of the Possible contamination with growth factors.

The increases in body
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,,eights in the' FSH and LH groups ranged from 68 g and 65 g ~ 59 g at 27
~.

103 and 101 vs 92 at 33 days; 127 and 126 vs 123 at 37 days,
(Tables I-IV). The 27 day differences were statistically significant
•

8
u-Y,

(P..0.01 and 0.02) after five days of injections while the 37 day variations were not significantly different.

This sudden increase in body size

and the resulting fall back into the normal range of the control groups
cannot be explained if these substances were pure

compounds~

The thyroid data shows the FSH and LH group mg% values to be consistently larger than the controls but analysis showed that these differences
were not significant. i·~· 6.8 mg and 7.3 mg vs 6.9 mg at day 27;
and 10.0

~

8.4 at day 33; 10.7 and 10.4

Text Figure I).

~

9.3

9.6 at day 37, (Tables I-IV,

The pituitary glands showed a similar relationship with

the values being larger but not significantly larger, i·~· 3.5 mg and 4.1
Jll8

Y!. 3.2 mg at day 27; 4.9 and 4.9 vs 4.4 at day 33; 6.2 and 6.7 vs 5.2

at day 37, (Tables I-IV, Text Figure II).

These similar weight comparisons

of the thyroid and pituitary glands to the controls might possibly be

ex~

plained by the presence of growth hormone factors in the FSH and LH preparations.
The uterine weights were all significantly larger than the controls,
which should be expected because of the gonadotropic effects on the
ovaries and their resulting effects

mg!!. 34

on the uteri, i.e. 49.4 mg and 124.5

mg at 27 days; 149.9 and 204.1 ~ 85.2 at day 33; 147.3 and 161.2

!!. 114.2 at day 37, (Tables I-IV, Text Figure III).
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premature sexual maturation as seen in the PGF2:'<-injected rats was
also present in the FSH and LR injected groups; and this was a

statistic~

ally significant difference from that of the control (P=0.001), (Table
III, Text Figure IV).

One hundred per cent of the rats in each group dis-

played open vaginal canalization at the time of necropsy at day 33.

These

gonadotropic hormones are directly responsible for the early activity of
the ovary which in turn initiates the uterine and vaginal development via
the ovarian steroids.

This activation of ovarian steroidogenesis may be

the same method by which the

PGF ~

2

group exerts its effect on premature

sexual maturity.
Analyzing the semi-quantitative histochemical estimates data of
the enzyme converting ovarian precursor of progesterone

(P-one-3~-HSD),

one finds seemingly increased levels of intensities in the 27 day FSH and
1H groups when compared to the controls,
V, Text Figure V).

~-~·

3.2 and 2.3

~

1.8, (Table

These differences, however, were not statistically

significant.
The FSH injected rat ovaries show decreased

P-one-3~-HSD

intensities

for the 33 and 37 day intervals as compared to controls, ~·~· 2.3 vs 3.0
and 1.4 vs 3.0 respectively, while the LR injected rat ovaries showed
similar P-one-3~-HSD intensities, as the control groups, i.e. each had
values of 3.0, (Table V, Text Figure V).
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DISCUSSION
While studying the biological effects of the prostaglandins, one is
iJDpressed with their wide distribution and their unparalleled ability to
aiodifY hormone actions, an effect now known to correlate with changes in
cyclic AMP levels within the different cell types.

Cyclic AMP is now con-

sidered the key intracellular mediator in tissue responses to many hormones

(Robison~!.!_.,

1971).

According to the current concept, the hor-

mones are released from their tissue or origin and travel via the circulation to the target tissue where they stimulate adenyl cyclase to catalyze
the conversion of adenosine triphosphate (ATP) to cyclic AMP, which in
turn induces the target tissue to respond.

The concept is complicated by

the multiplicity and diversity of the actions reported for cyclic AMP
and by the actions of other cyclic mononucleotides

(Robison~

al.1971).

Also, the prostaglandins can mimic many of the responses usually attributed
to cyclic AMP.

These interrelationships are neither simple nor well under-

stood.
Depending on the tissues or organs involved, prostaglandins either
increase or decrease the synthesis of cyclic AMP by adenyl cyclase or the
degradation of cyclic AMP by phosphodiesterase.

As an oversimplified

generalization, prostaglandins decrease cyclic AMP in adipose tissue and
toad bladder (Lipson and Sharp, 1971), and increase cyclic AMP in most
other tissues.

Studies with rat brown fat, and with canine, rabbit and

human fat, indicate species differences are involved which further co~pli
cate the picture (Bizzi, ~ !.!_., 1968; Hinman, 1972).

Prostaglandins E
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and F have already been reported to stimulate cyclic AMP formation in the
.
y , thyroid and uterus but this work was done in vitro while in
pitu1tar
i

~~

results are still forthcoming (Ramwell and Shaw, 1970).
The earlier sexual maturity and increased progesterone biosynthesis

in the ovaries revealed that the iniected PGF 2
effects on these immature rats.

« did,

indeed, have biological

These experiments, however, revealed no

biological effects, either gravimetrically or histologically, on the pituitaries, the thyroid glands and the uteri.

This in vivo experiment evalu-

ated the response of the animal in total equilibrium with all functioning

Despite the high rate of deactivation of injected prostaglandins by

~

the lungs and liver, enough

PGF ~

2

1teroidogenesis by day 27.

Further investigations into the histochemistry

did circulate to influence the ovarian

of the pituitary, thyroid and uterus would be of value to add to the in
vivo
........... knowledge of prostaglandin effects on immature animals .
A factor to consider is that, although the body weights tripled in
size from day 22 to day 37, the standard daily dose per rat remained conltant at 0.075

mg

BID and the delivered dosage per gram of·body weight

became progressively smaller.

This was unavoidable because of the

limited supply of PGF 2 o< compound.

Because of this, more significance

might be given to the 27 day increased ovarian progesterone biosynthesis
seen in the prostaglandin injected group.

The increased progesterone bio-

lynthesis undoubtedly was responsible for the premature sexual development
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Had the dosage of PGF2°' per gram of body weight been constant

ctudng this growth period, perhaps more obvious biological responses
would have been seen.

This provides another area for future investigation.

The dramatic effect of premature sexual development in immature rats
raises several areas for speculation.

Knowing that PGF 2 a

can mimic hor-

_,ne actions via increasing cyclic AMP levels in end-organ cell units, one
can only deduce from this experiment which hormone or hormones were mimicked.

undoubtedly, small amounts of estrogen(s) play a significant role

in early ovarian development which also commences the ovarian-pituitary
cycle (Velardo, 1958), but its exact location and source remains uncertain.

Therefore, the daily administration of

PGF 2 ~

may have indeed

mimicked the small amount of endogenous estrogen(s) needed to start
the maturity of the female reproductive systems.

This is supported by

other investigators who report that all prostaglandins, including

F ~

2

,

increase steroidogenesis (Speroff and Ramwell, 1970) and comment on their
wide variability in responses.

These results were based on in vitro luteal

1teroidogenesis and they seemingly contradict the luteolytic effects of
PGF2<it when large doses were given in vivo to rats (Pharriss and Wyngarden,

1969).

Pharriss and Hunter (1971) tried to solve this apparent contradic-

tion, but their interpretations of the in vitro versus in vivo experiments

to resolve this problem were difficult and confusing.
- -doses of PGF2°'

While higher

cause antagonism to luteolysis, lower doses would bring

•bout luteolysis.

They also stated that PGF2 a. administered did not

ltimulate ovulation but that uterine growth was stimulated when used in
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conjunction with Pregnant Mare Serum (PMS).

Their conclusions were based

he assumption that increased ovarian estrogen secretion altered the
on t
ratio of estrogen to progesterone thereby stimulating myometrial growth.
Velardo (1960), proved experimentally that both FSH and LR are
needed to induce ovulation; thus, might one imply that PGF 2 ot. could have,
indeed, mimicked several endogenous hormones to bring about this early
•turation?
The semi-quantitative enzyme histochemical analysis of the ovaries of
rats injected with

PGF ~

2

provided some clues to clarify which hormone or

hormones the prostaglandin is mimicking.

On day 27, the PGF group showed

the highest reading of all the experimental and control groups,

.!:~·

4.0. This was more than twice the activity as seen in the control ovaries,
1.8. The effects of this increased progesterone biosynthesis by the
ovaries is two-fold, (1) progesterone regulates the secretion of FSH and
1B from the pituitary (Burrows, 1949; Velardo, 1958), thus indirectly
affecting further ovarian development; and (2) progesterone has specific
effects on the uterus.
The gravimetric and enzyme cytochemistry of in

~

prostaglandin

rat ovaries deserves more scientific attention to determine if such an
effect was caused exclusively by an increase in progesterone biosynthesis.
The effects of prostaglandin F2C( on the uterus were not significant
either gravimetrically or histologically.

Obviously, enzymatic histo-

chemical analysis of these uteri will answer some of these perplexing
' questions.
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To complicate things more, other investigators are reporting a
decline in progesterone secretion following
sheep ovaries (Cahmley
tnecht,

~al.,

1971).

~al.,

PGF 2 ~

infusion using in vivo

1972) and those of pregnant hamsters (Gut-

They were measuring plasma progesterone levels

rather than ovarian biosynthesis, so in fact these results may still be
compatible.

But this does point out the confusion that results from

analyzing data from.!:.!!. vitro

~in ~studies

as suggested earlier.

perhaps these different effects may represent two different mechanisms of
action.
Pharriss and Wyngarden (1969) have proposed that PGF2Q( produces its
biological effects by venoconstriction producing a local ischemia via
reduced ovarian blood flow.

Therefore, one major difference explaining

the discrepancies between the in vitro and
of local hemodynamics.

~ ~

results is the effect

Relatively simple experiments could easily be

devised to answer this question.
It appears that the prostaglandins are leading us to the common
meeting ground where cellular communication and metabolism are being investigated.

The cell membrane is indeed coming to be recognized as a most

important crossroad for a great number of vital activities.

How prosta-

glandins mediate this cell-to-cell communication remains yet to be
explored, but to be sure, the role of prostaglandins with the formation
O~cyclic AMP is becoming increasingly important.
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SUMMARY AND CONCLUSION
A.

2

When prostaglandin F ~ was administered twice daily in 0.075 mg

ctoses beginning at day 22 in immature female rats, the first significant
observation was made on day 27 when the activity of P-one-3~-HSD in the
ovaries was more than twice that present in control ovaries.
B.

premature sexual development as witnessed by early vaginal canali-

sations was produced by the administered PGF 2 ~ and was observed by day
33 of the experiment.

The previous high levels of progesterone biosyn-

thesis undoubtedly played a role since early ovarian steroids are responsible for ovulation and puberty.

The exact role of this prostaglandin

was speculated as being directly responsible via end-organ response or
indirectly responsible via pituitary gonadotropins.

c.

By day 37, the ovarian progesterone biosynthesis was intensified

again, but the manifestation revealed by the histochemical assessments
could be ever so much more revealing when specific stages of estrous cycles
could be pursued.

Further investigations into the effects of prostaglan-

din and the different stages of estrus is therefore suggested, as an
extension of these original observations.
D.

No gravimetric or histologic differences were noted on the

pituitary, thyroid and uterus as they pertained to PGF 2d.. administration.

There were some minor weight variations but were not statistically significant.
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E.

Aspirin was used as a prostaglandin antagonist to determine

if any contrasting data would be obtained as it pertains to

PGF 2 ~

.

The concentration of injectable aspirin was determined and as the experi.-nt progressed, the body weights failed to keep up with the controls,
and with the presence of rough hair coats, a status of aspirin toxicity
was suspected.

This has undoubtedly interferred with some of the report-

able data obtained.

The delay of sexual maturity was the most obvious

contrasting phenomenon by the aspirin-administered rats.

This delay

could not be explained adequately by antagonizing prostaglandin·because
of the suspected toxicity present.

This may prove a fruitful area for

further research.
F.

Both FSH and LR groups by day 27 had significantly larger

body weights which were not in accord with pure FSH and IJl responses.
This complicated the other results observed in these groups ie. uterine
responses and ovarian progesterone biosynthesis.

Having a pure compound

of FSH and IJl would have enabled a reliable pattern of organ growth and
development to which the prostaglandin grdup could be compared.

Further

experimental trials using such compounds in conjunction with and without
prostaglandins would be revealing.
G.

Thus, in sum, the hall-mark noted effects of PGF2 d,. in these

experiments are two in number: (a)

PGF 2 ~

2

induced early vaginal canaliza-

tion, and (b) PGF ~ elicited comparatively high intensities of the progesterone precursor in the maturing ovary.
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VAGINAL OPENINGS AND THE GRAVIMETRIC COMPARISONS OF BODY, THYROID, 'PrrtJI.TAR.Y AND UTERI.NE 'WEl.GMS 01!' nn?.
NORMAL CONrROL GROUPS OF ALB I.NO RATS

Age
in
Days

22

~

Bodl'.: Wt.

Thl:roid Wt.

Pituitarl'.: Wt.

Uterus Wt.

g, mg(a)
range

41+5 .'3 (b)
36-=51

4.7
3.0-6.8

2.2
1.3-2.8

20.2
17.4-24.7

11.5+2. 2
8.3-15.5

5.4+1. l
3.6:-7.1

50.0+7 .6
34.9:-62.2

6.9
5.7-8.7

3.2
2.8-4.0

34.0
26.5-52.8

11.7+1.0
13.3:-10.5

5.5-t-0.15
4. 7:'6.5

56. 6+10. 6
43.2:-73.4

8.4
6.1-12.4

4.4
4.1-5.2

85.2
46.8-165.2

9 .O+l. 9
7.3:-13.3

4.8-t-0.4
4. 2:-5. 6

92.0+46.9
51. 2:'127. 6

mg%
range

27

g, mg
range

59+7. 5
51:'73

mg%
range

33

g, mg
range
mg%
range

92+6 .4
84:-102

-Continued-

Vaginal
02enin~s(c)

0/10

0/10

0/9

Age

in
Days
37

Pituitary wt.

uterus Wt.

Item

Body Wt.

Thyroid Wt.

g, mg
range

123+12. 3
ln:-149

9.6
6.9-12.7

5.2
3.6-7.1

114.2
50.8-219.9

7. 9+1. i
6.2:-9.6

4.2+o.7
3. 0:-5 .1

92 .5+31. 9
42.7:-157.1

mg%

range
8 Body

Vaginal
Openings

10/10

weights are shown in grams (g), organ weights in milligrams (mg).

bArithmetic mean followed by the standard deviation.
cFigure before diagonal represents number of rats with vagina open at time of necropsy; figure
after diagonal represents number of rats in age group.

TABLE '.t'I

VAGINAL OPENINGS AND THE GRAVIMETRIC COMPARISONS OF BODY, THYROID, PTIUTIARY AND
UTERINE WEIGHT OF 27 DAY OLD GROUPS TO CONTROL GROUPS OF ALBINO RATS

Grou~

Item

Body Wt.

Thyroid Wt.

Pituitary Wt.

Uterus Wt.

Vaginal Openings(c)

Alcohol
Control

g, mg(a)
range

60+7.6(b)
50:-71

7.1
5.7-8.6

3.3
2.9-4.1

34.3
26.5-52 6

0/10

mg%
range

11. 5+1. 7
4. 9-6.6

5.5+o.5
45.7-74.1

58.2+9.3

10.4-13.8

g, mg
range

55+5. 5
49:-69

6~7

5. 7-8.2

3.0
2.6-3.3

34 2
22.2-48 7

11. 8+1.1
9.8-13.9

5.5+o.5
4.8:-5.9

61. 5+10.4
53.2:-82.1

6.0
5.2-7.0

3.4
3.0-4.2

26.6
18.8-37.2

11.2+o.9
10 2+13.0

6. 3+1.1
4.8:-8.4
<0.05

49.0+8.5
41. 9:-60.4

PGF2ot

mg%
range
Aspirin

g, mg
range
mg%
range
Pro ba bi l i ty

54-+4.5
47:-62

- Continued -

-

0/10

0/8

Group

Item

Body Wt.

Thyroid Wt.

Pituitary Wt.

Uterus Wt.

Vaginal Openings

FSH

g, mg
range

68-+8.l
56:-84

6.8
5.8-9.2

3.5
2.9-4.8·

49.4
36.0-73.6

0/10

10.1+1.4
8.1-12 1

5.1+1.0
3.9:-7.1

64-9+13. 5
54.6:-87.6

7.3
6.2-8.2

4.1
3.6-4.9

124.5
74.8-193.0

11.2+1.0
9 .1-r2. 5

6.3+o.6
5.5:-7.3
<0.01

191. 5+62. 8
110. o:-3oi. 6
<0.001

mg%
Range
Pro ba bi 1i ty
LR

g, mg
range

<0.02
65+3.6
60:-71

mg%
range
Probability

<0.01

0/10

aBody weights are shown in grams (g), organ weights are shown in milligrams per 100 grams body
weight (mg%).
bAverage weight

± the

standard deviation.

cFigure before diagonal represents number of rats with vagina open at time of necropsy; figure
after diagonal represents number of rats in age group.

VAGINAL OPENINGS AND THE GRAVIMETRIC COMPARISONS OF BODY, THYROID, 'PITUITARY A.ND
UTERINE WEIGHT OF 33 DAY OI.D GROUPS TO CONTROL GROUPS OF ALBINO RA.TS

GrouI!

Item

Bodz wt.

Thyroid Wt.

Pituitarx wt.

Uterus Wt.

Vaginal 012enings(c)

Alcohol
Control

g' mg (.a)
range

93+7 .4(b)
807105

8.8
6.3-12.9

4.6
4.1-5.3

87.5
48.2-180.8

1/10

9. 5+2. 5
6.8713.9

4.9+-0.5
4.175.6

93.6-146.6
51. 37180

8.4
6.0-10.8

4.3
3.5-4.8

75.9
44.1-154.5

9 .4+2. 0
5.9712.8

4.9+1. l
4.276.0

82. 2-141. 5
39.37153.0

mg%
range
PGF2ci1.

g' mg
range

90+11.2
787109

mg%
range
Probability
Aspirin

g, mg
range
mg%
range

9/10

<0.001
89+12. 7
787112

8.9
7.0-11.4

4.5
3.7-5.7

70.9
44.3-156.2

10. 0+2 .4
7.5-l3.8

5.1+-0.5
4.4:-5.6

78.5-144.2
44.8:-173.6

- Continued -

1/7

GrouE

Item

Bod~

FSH

g' mg
range

103+12 .2
89-l25

Wt.

mg%

range
Probability

Pituitarr wt.

Uterus Wt.

va~inal Openin~s

9.3
7.9-11.3

4.9
4.0-6.0

149.9
89.5-216.4

10/10

8.9+1.0
7.3:-10.9

4.8-+-0.5
4.o:-s.6

143.1+39 .1
89.5-l97.9
<0.02

<0.05
101+16.2
64-117

g' mg
range

Thrroid Wt.

mg%

range
Probability

10.0
7.8-11.7

5.9
4.0-7.l

204.l
145.6-290.4

10. 0+1. 2
8.9-12.2

5.9-+-0.7
4.6:-7.1
<0.001

210 .4+77. 9
136.2:-259.3
<0.001

<0.001
9/9

<0.001

8 Body

weights are shown in grams (g), organ weights are shown in milligrams per 100 grams body
weight (mg%).
bAverage weight

± the

standard deviation.

cFigure before diagonal represents number of rats with vagina open at time of necropsy; figure
after diagonal represents number of rats in age group.

TABU: N

VAGINAL OPENINGS AND THE GRAVIMETRIC COMPARISONS OF BODY, THYROID AND UTERINE
WEIGHTS OF 37 DAY OLD GROUPS TO CONTROL GROUPS OF ALBINO RATS

Groue

Item

Body wt.

Thyroid Wt.

Pituitary Wt.

Uterus Wt.

Vaginal Openings(c)

Alcohol
Control

g, mg(a)
range

122+13.9(b)
109:-155

9.7
7 .2-11.9

5.2
4.1-7.l

117 .4
51. 3-221.4

10/10

8.0+1.0
6.4:-9.3

4.3-+-0.8
3.1:-5.3

96.2+33.0
42.4:-164.0

10.0
8.0-13.6

5.2
4.2-6.1

107 .9
62.8-143.1

8. 6+1. 9
5.8:-11.3

4.3-+-0. 7
3.3:-5.8

80. 3+29.0
53.7:-132.3

9.2
6.8-10.8

5.2
4.1-6.2

109.3
36.5-167.1

8.4+1.0
7.0:-10.1

4.8-+-0.6
4.o:-5.6

103. 2-+43 .1
41. 7-l62. 6

mg%
range
PGF2«

g, mg
range

120+15.6
88-l39

mg%
range

Aspirin

g, mg
range
mg%
range
Probability

110+12 .1
85-122

<(). 05

- Continued -

9/9

6/8 (75%)

Group

Item

Body Wt.

Thyroid Wt.

Pituitary Wt.

Uterus Wt.

vaginal Openings

g, mg

127+8.l
n5:-142

10. 7
8.5-12.0

6.2
5.0-7.0

147. 3
113.3-207.2

10/10

FSH

8.6+1.4
6. 9:-11. 5

4.9+-0.4
4.2°=5. 1
<0.02

117 .0+28. 6
79.8-l63.9
<O.l

10.4
8.6-11.3

6.7
5. 1-8.0

161.2
138.7-195.7

5.4+o. 8
3.9:-6.2
<0.01

128.4+11. 8
105.9:-147.4
<0.01

range
mg%

range
Probability

LR

g, mg

range

126+9. 3
1107144

mg%

range
Probability

10/10

aBody weights are shown in grams (g), organ weights are shown in milligrams per 100 grams body
weight (mg%).
bAverage weight

± the

standard deviation.

cFigure before diagonal represents number of rats with vagina open at time of necropsy; figure
after diagonal represents number of rats in age group.

TABLE V

SUMMARIZED DATA BASED ON SEMI-QUANTITATIVE HISTOCHEMICAL ANALYSIS OF PREGNENOLONE-3B-RSD A.CTIVITY IN
THE OVARIES OF ALBINO RATS

Age
in
Days
27

Control

PGF20t

Aspirin

FSH

LH

l.8+o.96(a)
1 --3(b)
5(c)
Probability

4. 0+1.41
2 --5

2.3+1.26
1 --4
4

3. 2+1.58
1 - 5
5

2.3+1.09
1 --3
5

<0.05

3.0+o.82
2 -4

2.3+1.26
1 --4

3.0+o.82
2 --4

4

5

3

2. 3+1.5
1 --4
5
<0.005

3.0+o.82
2 --4
4

4. 2+o. 84
3 --5
4
<0.05

2.5+o.58
2 --3
4

1.40+o. 56

3.0+o. 71
2 --4
5

33

5

Probability
3. o+o. 71
2 -4
5
Pro ba bi 1i ty

37

1 5

2

<0.005

aArithmetic average + the standard deviation based on semi-quantitative histochemical estimates of
pregnenolone-3B-HSD activity as observed on ovarian sections. Scale ranges from +l to +5.
bRange
cNumber of rats in group.

GRAVIMETRIC COMPARISON OF THYROID GLA.NDS OF RATS BASED UPON THE WEIGHT OF THE ORGA.N 'PER 100 G'RA.MS
OF BODY WEIGHT (mg%)
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GRAVIMETRIC COMPARISONS OF THE PITUITARY GI.ANDS OF RATS BASED ON THE ORGAN WEIGH.TS PER 100 GRAMS OF
BODY WEIGHT (mg%)
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GRAVIMETRIC COMPARISONS OF THE UTERINE WEIGHTS OF RATS BASED UPON THE ORGAN WEIGHT PER 100 GRAMS O'F
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TEXI FIGURE r1

SUMMARY OF DATA CONCERNING VAGINAL OPENINGS OF RATS DETERMINED AT TIME OF NECROPSY, BASED ON A P'ERCENrAGE OF VAGINAL OPENINGS
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SEMI-QUANTITATIVE COMPARISONS OF PREGNENOLONE-3B-HSD ACTIVITY IN THE OVARms OF RATS BASED ON A REIATIVE
SYSTEM OF +l TO +5

Control
PGF 2 Cl
Aspirin
FSH

LR

5
Activity of
Pregneno lone3B-HSD in
4
Ovaries

3

2

1

27

33
Age in Days

37

0-0
>H<

.......

&-/l

48

Introductory Note to Plates
All photomicrographs are of cross sections of ovaries.

Photomicro-

graphs were taken using Polaroid type 107 film and a Wild microscope.
All photomicrographs are at lOOX magnifications.

...
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PIATE I

PIATE I
Photomicrographs of rat ovarian sections, normal H&E is portrayed in
Figure 1, the control is Figure 2 and Figure 3 was incubated with pregnenolone demonstrating the appearance of pregnenolone-3~-hydroxysteroid
dehydrogenase (P-one-3~-HSD) in the form of precipitated deposits which
localize the sites of the biosynthesis of progesterone. These photomicrographs were semi-quantitatively evaluated on a sc,ale of 0 to +5
depending upon the amount of precipitate formed. All photographs are at
lOOx.

Fig. · 1.

Fig. 2. Control section of ovary incubated without pregnenolone.
resents a zero reaction (lOOX).
Fig. 3. Represents a +l reaction.
visible.

--rr;?-l.

.

n --

Fig. 1. Control ovarian section stained with H&E to demonstrate the
appearance of the ovarian structure (lOOX).
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1

Rep-
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very little diformazan deposits

Fig.
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Fig.

3.
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PIATE II

Plate II

,.
Photomicrographs of rat ' ovarian sections which were incubated with
pregnenolone demonstrating the appearance of pregnenolone-3~-hydroxy- ,
steroid dehydrogenase (P-one-3~-HSD) in the form of precipitated deposits which localize the sites of the biosynthesis of progesterone.
These photomicrographs were semi-quantitatively evaluated on a scale of
0 to +5 depending upon the amount of precipitate formed. All photographs
are at lOOX.

Fig • .

4.

Fig.

5.

Fig. 4. Represents a +2 reaction. Few deposits are in evidence indicating slight P-one-3~-HSD activity.
Fig. 5.

Repre.sents a +3 reaction.

M::>re discrete deposits are visible.

Fig. 6.

Represents a -+4 reaction.
activity are visible.

Larger areas of more dense P-one-

3~-HSD

r:. '

rr.:
.- -.: .
t!'" _. .
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Fig.
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PI.ATE . III
Plate III
Photomicrographs of rat ovarian sections which were incubated with
pregnenolone d~monstrating the appearance of pregnenolone-3~-hydroxy
steroid' dehydrogenase (P-one-3~-HSD) in the form of precipitated deposits which localize the sites of the biosynthesis of progesterone.
These photomicrographs were semi-quantitatively evaluated on a scale of
0 to +5 depending on the amount of precipitate formed. All photographs
are at lOOX.

Fig. · 7.

Fig. 7. Represents a +5 reaction. Confluent areas of dense deposits
demonstrated indicating highest activity of P-one-3~-HSD present.
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PLATE

rY

Plate IV
Photomicrographs of sections of ovaries from the non-injected
control rats which were ,incubated with pregnenolone and nictotinamide
adenine dinucleotide (NAD) to localize the activity sites of progesterone
biosynthesis.
Fig. 8. Ovarian section from a 33 day bld non-injected control rat,
showing +2 P-one-3~-HSD activity in the interstitial tissue (lOOX).
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Fig. 9. Ovarian section from a 37 day old non-injected control rat,
showing +3 P-one-3~-HSD activity in the sub-capsular interstitial
tissue.
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Plate V
PLA'l'E

V

Photomic-rographs· of sections of ovaries from the PGF20< injected
rats whi~h were incubated with pregnenolone to localize the sites of
progesterone biosynthesis.
Fig. 10. Ovarian section from a 27 day old PGF20( injected rat showing
maximum +5 P-one-3~-HSD activity in the intestitial tissue and in
the theca interna of the follicles (lOOX).

Fig.

10.
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